Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Premier Biotech LLC has 5 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 5 distinct examiners and 4 distinct art units. HEALY, NOAH MICHAEL is the busiest examiner, responsible for 1 pending office action. The presence of 5 examiners across 4 distinct art units suggests a varied but somewhat clustered technical review process at the patent office.
With 5 pending office actions and 5 distinct examiners, the company must navigate 5 separate sets of examiner preferences. However, the fact that these are contained within 4 distinct art units indicates some overlap in the technical classifications of the pending matters. Practitioners must manage these 5 examiner relationships while being mindful of the standards across the 4 distinct art units. No single examiner, including HEALY, NOAH MICHAEL, has a dominant influence over the portfolio, as each handles only 1 action. This distribution provides a range of feedback from different experts, which can help in refining the company's overall intellectual property strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HEALY, NOAH MICHAEL | 1 | 54.0% | +41.4% |
| PATEL, NIDHI NIRAJ | 1 | 52.9% | +47.5% |
| KRCHA, MATTHEW D | 1 | 64.3% | +35.5% |
| GERHARD, ALISON CLAIRE | 1 | 40.9% | +21.7% |
| SIEFKE, SAMUEL P | 1 | 63.0% | +17.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18990081 | ASSEMBLY AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING | HEALY, NOAH MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16875583 | SCREENING DEVICE FOR ANALYSIS OF BODILY FLUIDS | SIEFKE, SAMUEL P | 100d overdue |
| 18990081 | ASSEMBLY AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING | HEALY, NOAH MICHAEL | — |
| 18775773 | DEVICE AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING | PATEL, NIDHI NIRAJ | — |
| 18703518 | DEVICE FOR DETECTING ANALYTE IN FLUID SAMPLE | KRCHA, MATTHEW D | — |
| 17970001 | DEVICE FOR TESTING AN ANALYTE IN A LIQUID SAMPLE | GERHARD, ALISON CLAIRE | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1796 | 1 |
| 1797 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18990081 | ASSEMBLY AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING | HEALY, NOAH MICHAEL | 3791 | §103§112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18775773 | DEVICE AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING | PATEL, NIDHI NIRAJ | 3791 | §103 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18703518 | DEVICE FOR DETECTING ANALYTE IN FLUID SAMPLE | KRCHA, MATTHEW D | 1796 | §102§103§112DP | Non-Final OA | — | Pending | Apr 22, 2024 |
| 17970001 | DEVICE FOR TESTING AN ANALYTE IN A LIQUID SAMPLE | GERHARD, ALISON CLAIRE | 1797 | §103 | Final Rejection | — | Pending | Oct 20, 2022 |
| 16875583 | SCREENING DEVICE FOR ANALYSIS OF BODILY FLUIDS | SIEFKE, SAMUEL P | 1758 | DP | Final Rejection | 100d overdue | Pending | May 15, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPremier Biotech LLC has 5 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Noah Michael Healy has the most, with 1 of Premier Biotech LLC's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
